83 related articles for article (PubMed ID: 852974)
1. Effect of 1alpha-hydroxycholecalciferol in senile osteoporosis and in bone loss following prednisone treatment.
Sorensen OH; Lund B; Friis TH; Hjorth L; Reimann I; Kjaer I; Andersen RB
Isr J Med Sci; 1977 Mar; 13(3):253-8. PubMed ID: 852974
[TBL] [Abstract][Full Text] [Related]
2. Treatment of osteoporosis of ageing with 1alpha-hydroxycholecalciferol.
Lund B; Hjorth L; Kjaer I; Reimann I; Friis T; Andersen RB; Sorensen OH
Lancet; 1975 Dec; 2(7946):1168-71. PubMed ID: 53656
[TBL] [Abstract][Full Text] [Related]
3. Bone density loss during treatment of chronic GVHD.
Stern JM; Chesnut CH; Bruemmer B; Sullivan KM; Lenssen PS; Aker SN; Sanders J
Bone Marrow Transplant; 1996 Mar; 17(3):395-400. PubMed ID: 8704693
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
[TBL] [Abstract][Full Text] [Related]
6. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
Jones G; Hogan DB; Yendt E; Hanley DA
CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
[TBL] [Abstract][Full Text] [Related]
7. Treatment of senile osteoporosis with 1alpha-hydroxyvitamin D3.
Sørensen OH; Andersen RB; Christensen MS; Friis T; Hjorth L; Jørgensen FS; Lund B; Melsen F; Mosekilde L
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():169s-175s. PubMed ID: 342143
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study.
Geusens P; Dequeker J
Bone Miner; 1986 Sep; 1(4):347-57. PubMed ID: 3333018
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density changes in women with systemic lupus erythematosus.
Boyanov M; Robeva R; Popivanov P
Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
[TBL] [Abstract][Full Text] [Related]
10. Prevention of corticosteroid-induced osteoporosis by alfacalcidol.
Lakatos P; Nagy Z; Kiss L; Horvath C; Takacs I; Foldes J; Speer G; Bossanyi A
Z Rheumatol; 2000; 59 Suppl 1():48-52. PubMed ID: 10769437
[TBL] [Abstract][Full Text] [Related]
11. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
Bikle DD
Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
[TBL] [Abstract][Full Text] [Related]
12. Letter: Calcitonin in steroid-induced osteoporosis.
Palmieri GM; Dvorak J; Bottomley R
N Engl J Med; 1974 Jun; 290(26):1490-1. PubMed ID: 4831772
[No Abstract] [Full Text] [Related]
13. [The effect of estrogen and, sex-steroids and thyroid hormone preparation on bone mineral density in senile osteoporosis--a comparative study of the effect of 1 alpha-hydroxycholecalciferol (1 alpha-OHD3) on senile osteoporosis].
Shiraki M; Orimo H
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):84-95. PubMed ID: 1645679
[TBL] [Abstract][Full Text] [Related]
14. Changes in bone histomorphometry and bone mineral during treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Nilsson OS; Elmstedt E; Eriksson SA; Lindholm TC; Kyhle BR
Acta Vitaminol Enzymol; 1981; 3(3):170-6. PubMed ID: 7347489
[TBL] [Abstract][Full Text] [Related]
15. The effect of 1alpha-hydroxycholecalciferol and hormone therapy on the calcium balance of post-menopausal osteoporosis.
Marshall DH; Gallagher JC; Guha P; Hanes F; Oldfield W; Nordin BE
Calcif Tissue Res; 1977 May; 22 Suppl():78-84. PubMed ID: 334349
[No Abstract] [Full Text] [Related]
16. 1alpha-hydroxycholecalciferol. Long-term treatment of patients with uraemic osteodystrophy.
Nielsen SP; Binderup E; Godtfredsen WO; Jensen H; Ladefoged J
Nephron; 1976; 16(5):359-70. PubMed ID: 1264309
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1alpha-hydroxycholecalciferol on osteoporotic changes induced by calcium deficiency in bone fractures in adult rats.
Lindholm TS
J Trauma; 1978 May; 18(5):336-40. PubMed ID: 660687
[TBL] [Abstract][Full Text] [Related]
18. [Iatrogenic osteoporsis: six case reports].
Zheng LM; Wang JZ
Zhonghua Nei Ke Za Zhi; 1994 Oct; 33(10):658-60. PubMed ID: 7712909
[TBL] [Abstract][Full Text] [Related]
19. Calcium supplements in the prevention of steroid-induced osteoporosis.
Reid IR; Ibbertson HK
Am J Clin Nutr; 1986 Aug; 44(2):287-90. PubMed ID: 3728366
[TBL] [Abstract][Full Text] [Related]
20. [Effects of the treatment of active osteoporosis on the urinary excretion of hydroxyproline].
Rico Lenza H; del Rio Vázquez A; Vázquez Salamanica E; Espinos Pérez D
Rev Clin Esp; 1979 Apr; 153(2):103-6. PubMed ID: 482672
[No Abstract] [Full Text] [Related]
[Next] [New Search]
